Reprogramming Tumor-Associated Macrophages To Reverse EGFR<sup>T790M</sup> Resistance by Dual-Targeting Codelivery of Gefitinib/Vorinostat
Huige PengShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaBinfan ChenShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWei HuangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYubo TangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYifan JiangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaWenyuan ZhangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, ChinaYongzhuo HuangShanghai
Institute of Materia Medica, Chinese Academy of Sciences, Shanghai 201203, China
2017en
ABI
Аннотация
-caused resistance to tyrosine kinase inhibitor treatment.
Перевод пока недоступен
Идентификаторы
Цитирования и источники
Цитирований: 3Использованных источников: 0